ZYC-200

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameZYC-200
Drug Alias NameZYC200
ClassificationBiologics
Mechanisms of ActionImmunosuppressantsMelanocortin receptor 1 agonists
TargetsMelanocortin receptor 1
Therapy Area/IndicationsMultiple SclerosisAsthmaInflammatory Bowel Diseases +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMgi Pharma Biologics, Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMgi Pharma Biologics, Inc
Active IndicationsN/A
Inactive IndicationsMultiple SclerosisAsthmaInflammatory Bowel Diseases +[4

Other Information

ATC CodeN/A
Related LinksN/A